Document:

Unassociated Document

    

    EXHIBIT
      10.5

    

    

    

    LICENSE
      AGREEMENT

    

    THIS
      LICENSE AGREEMENT (this "Agreement") is made as of April 15, 2008 (the
“Effective Date”) by and between Hybrid Technologies, Inc., a Nevada corporation
      having an address at 5841 East Charleston, Suite 230-145, Las Vegas, NV 89142
      ("Hybrid"), and Zingo Inc., a Nevada corporation having an address at 420 N.
      Nellis Blvd., Suite A3-146, Las Vegas, NV 89110. ("Zingo").

     

    RECITALS

    WHEREAS,
      Hybrid owns and has the right to license the Patent Rights (defined below);
      

    WHEREAS,
      Hybrid desires to exclusively license to Zingo, and Zingo desires to obtain
      a
      license from Hybrid to, the Patent Rights; 

    NOW,
      THEREFORE, the parties agree:

    

    ARTICLE
      1.

    DEFINITIONS

    

    The
      terms, as defined herein, shall have the same meanings in both their singular
      and plural forms.

    1.1 “Affiliate”
      means any corporation or other business entity in which Zingo owns or controls,
      directly or indirectly, more than fifty percent (50%) of the outstanding stock
      or other voting rights entitled to elect directors, or in which Zingo is owned
      or controlled directly or indirectly by more than fifty percent (50%) of the
      outstanding stock or other voting rights entitled to elect directors.

    1.2 “Licensed
      Field” means rechargeable lithium-ion batteries for hybrid vehicles
      and other applications.

    1.3 “Licensed
      Product” means any product for which the manufacture, use, sale, offer for sale,
      or importation would constitute, but for the license granted to Zingo by Hybrid
      herein, an infringement of any Valid Claim within the Patent
      Rights.

    1.4 “Patent
      Rights” means any and all patents and patent applications (including inventor's
      certificates and utility models) listed on Exhibit A, including any
      substitutions, extensions, reissues, reexaminations, renewals, divisions,
      continuations, continuation-in-parts and foreign counterparts of any of the
      foregoing.

    1.5 “Retained
      Field” means any products outside of the Licensed Field.

    1.6 “Valid
      Claim” means any patent claim within the Patent Rights that has not expired or
      been held invalid in a final decision by a patent office or by a court of
      competent jurisdiction.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    ARTICLE
      2.

    GRANT

    2.1 License.
      Hybrid hereby grants to Zingo, and Zingo hereby accepts, a worldwide, exclusive,
      perpetual license, under the Patent Rights, to make, use, sell, offer for sale
      and import Licensed Products and practice any methods covered by the Patent
      Rights, solely within the Licensed Field. Zingo shall have the right to
      sublicense under this Agreement only with (i) the consent of Hybrid and (ii)
      Hybrid’s approval of the terms of each such sublicense.

    2.2 Developmental
      Capital. Zingo shall invest not less than One Million Five Hundred Thousand
      Dollars ($1,500,000) in the development of the Licensed Products in each of
      the
      first two years after the Effective Date, for a total investment of not less
      than Three Million Dollars ($3,000,000) in the first two years after the
      Effective Date.

    2.3 Delivery.
      Hybrid will deliver to Zingo tangible examples and prototypes of the Patent
      Rights in the Licensed Field, including any schematics, diagrams, designs and
      molds, held by Hybrid. 

    

    ARTICLE
      3.

    PREFERENTIAL
      PURCHASE RIGHTS AND PRICING; LEASE

    3.1 Preferential
      Purchaser. Hybrid shall have the right to purchase its requirements of lithium
      ion batteries from Zingo. Hybrid’s requirements of lithium ion batteries shall
      be supplied to Hybrid in preference to, and on a priority basis as compared
      with, supply and delivery arrangements in effect for other customers of
      Zingo.

    3.2 Sales
      at
      Cost. Hybrid’s cost for lithium ion batteries purchased from Zingo shall be
      Zingo’s actual manufacturing costs for such batteries for the fiscal quarter of
      Zingo in which Hybrid’s purchase takes place. Hybrid shall have the right to
      audit Zingo’s manufacturing costs as provided in Article 4.

    3.3 Lease.
      Effective April 16, 2008, Zingo will lease approximately 5,000 square feet
      of
      space (“Leased Space”) in Hybrid’s North Carolina facility, such Leased Space to
      be suitable for, and utilized by Zingo for, Zingo’s developmental and
      manufacturing operations for Licensed Products pursuant to this Agreement.
      The
      Leased Space shall be leased by Hybrid to Zingo on a month-to-month basis at
      a
      monthly rental of $2,500, the monthly rental to be escalated five (5%) percent
      annually.

    3.4 
      Sale of
      Equipment and Supplies. Effective April 16, 2008, Hybrid shall sell to Zingo
      for
      the purchase price of $29,005, and Hybrid hereby assigns, transfers and sells
      to
      Zingo, the equipment and supplies related to the Licensed Field listed on
      Exhibit B hereto.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    

    

    ARTICLE
      4.

    AUDIT
      RIGHTS

    4.1 Records
      & Audits.

    (a) Zingo
      shall use reasonable efforts to keep accurate and correct records of all
      Licensed Products manufactured, used, and sold, and sublicense fees received
      under this Agreement. Such records shall be retained by Zingo for at least
      two
      (2) years following a given reporting period.

    (b) All
      records of Zingo and its Affiliates and Sublicensees shall be available during
      normal business hours for inspection at the expense of Hybrid by a nationally
      recognized certified public accountant selected by Hybrid and acceptable to
      Zingo for the sole purpose of pricing of lithium batteries to Hybrid. Such
      inspector shall not disclose to Hybrid any information other than information
      relating to the accuracy of reports and payments made under this Agreement
      or
      other compliance issues. In the event that any such inspection shows an
      overcharge to Hybrid in excess of ten percent (10%) for any twelve (12) month
      period, then Zingo shall pay the cost of the audit as well as any additional
      sum
      that would have been not been payable by Hybrid had Zingo priced lithium ion
      batteries sold to Hybrid correctly.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    ARTICLE
      5. 

    PATENT
      MATTERS

    5.1 Patent
      Prosecution and Maintenance.

    (a) Zingo
      shall have the right to control, at its expense and with counsel of Zingo’s
      choice, the prosecution and maintenance of the Patent Rights as they pertain
      to
      the Licensed Field (the “Licensed Field Patent Rights”). Hybrid shall provide
      Zingo with copies of all relevant documentation relating to such prosecution.
      Hybrid shall cooperate in good faith and use diligent efforts to support Zingo’s
      prosecution and maintenance activities.

    (b) Hybrid
      agrees that if Zingo is unable because of Hybrid’s unavailability, dissolution
      or for any other reason to secure any signatures in connection with the
      prosecution and maintenance of the Licensed Field Patent Rights, then Hybrid
      hereby irrevocably designates and appoints Zingo and its duly authorized
      officers and agents as Hybrid’s agent and attorney in fact, to act for and in
      Hybrid’s behalf and stead to execute and file any documents and to do all other
      lawfully permitted acts to further the prosecution, issuance and maintenance
      of
      the Licensed Field Patent Rights with the same legal force and effect as if
      executed by Hybrid.

    (c) In
      the
      event Zingo desires to terminate or cease maintenance of any Licensed Field
      Patent Rights, it shall notify Hybrid, and Hybrid shall have the opportunity
      to
      control, at its expense, the prosecution and maintenance of such Licensed Field
      Patent Rights. 

    (d) Hybrid
      will promptly provide to Zingo copies of all existing files and records
      pertaining to the Licensed Field Patent Rights, including without limitation
      all
      office actions, drafts, receipts, drawings, correspondence, disclosures, models,
      copies, prototypes, diagnostic reports, prior art and analyses. 

    5.2 Patent
      Infringement.

    (a) Each
      party shall notify the other party in writing of any suspected infringements
      of
      the Patent Rights.

    (b) Zingo
      shall have the right, but not the obligation, to institute and control the
      prosecution of a suit or to take any other action for any of the Licensed Field
      Patent Rights. Hybrid agrees to take no action with respect to any third-party
      infringement of Licensed Field Patent Rights unless expressly authorized to
      do
      so in writing by Zingo. Hybrid agrees to cooperate with Zingo in all respects,
      to make employees of Hybrid available to testify, and to join in any such suit
      as a voluntary plaintiff, upon Zingo’s request. 

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    (c) Any
      recovery or settlement obtained as a result of such suit or other action shall
      be retained by Zingo, and Hybrid shall have no rights whatsoever in any such
      recovery or settlement, except that any such recovery or settlement shall be
      treated as a reduction in Zingo’s manufacturing costs, for purposes of
      calculating sale prices of lithium ion batteries to Hybrid, after deduction
      of
      costs and expenses incurred by Zingo in bringing and controlling any such suit
      or action.

    (d) In
      the
      event the suspected infringement is in the Retained Field, then the parties
      shall discuss in good faith and strategize regarding the institution and
      prosecution of a suit or other action.

    5.3 New
      Inventions. Zingo shall have all rights, title and interest in and to any
      improvements or modifications to the Patent Rights only as they pertain to
      any
      inventions within the Licensed Field that are conceived, reduced to practice
      or
      otherwise invented by or for Hybrid (the “Licensed Field Improvements”) during
      the term of this Agreement. Hybrid hereby makes any assignments to accomplish
      the foregoing ownership provision. Hybrid agrees to assist Zingo in every proper
      way (including, without limitation, becoming a nominal party) to evidence,
      record and perfect the assignment and to apply for and obtain recordation of
      and
      from time to time enforce, maintain and defend such proprietary right. In the
      event it is not practical or feasible to assign rights within the Licensed
      Field
      separate from rights in the Retained Field, then Hybrid hereby grants to Zingo
      an exclusive, perpetual, irrevocable, royalty-free, sublicensable license to
      practice and exploit the Licensed Field Improvements.

    5.4 Retained
      Field. Hybrid shall continue as responsible for all research and development
      relating to the Patent Rights and shall retain all rights, title and interest
      in
      and to the Patent Rights, or any improvements or modifications to the Patent
      Rights only as they pertain to any inventions within the Retained Field that
      are
      conceived, reduced to practice or otherwise invented by or for Tru-Light (the
      during the term of this Agreement (the “Retained Field Patent Rights”). Zingo
      hereby makes any assignments to accomplish the foregoing ownership provision.
      Zingo agrees to assist Hybrid in every proper way (including, without
      limitation, becoming a nominal party) to evidence, record and perfect the
      assignment and to apply for and obtain recordation of and from time to time
      enforce, maintain and defend such proprietary right. In the event it is not
      practical or feasible to assign rights within the Retained Field separate from
      rights in the Licensed Field, then Zingo hereby grants to Hybrid an exclusive,
      perpetual, irrevocable, royalty-free, sublicensable license to practice and
      exploit such Retained Field Patent Rights.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    ARTICLE
      6.

    TERMINATION
      OF THE AGREEMENT

    6.1 Term.
      Unless terminated earlier in accordance with this Article, this Agreement shall
      be effective beginning on the Effective Date and ending on the expiration date
      of the longest-lived Valid Claim.

    6.2 Termination
      by Hybrid. If Zingo materially fails to perform or materially violates any
      term
      of this Agreement, then Hybrid may give written notice of default ("Notice
      of
      Default") to Zingo. If a Notice of Termination is sent to Zingo, this Agreement
      shall automatically terminate on the effective date of that notice.

    6.3 Termination
      by Zingo. Zingo shall have the right at any time and for any reason, or no
      reason at all, to terminate this Agreement upon a ninety (90) day written notice
      to Hybrid. Said notice shall state Zingo’s reason for terminating this
      Agreement.

    6.4 Survival
      on Termination. Articles 4,5, 6 and 8 shall survive the termination or
      expiration of this Agreement. 

    6.5 Disposition
      of Licensed Products on Hand. Upon termination of this Agreement, Zingo shall
      return to Hybrid any tangible examples and prototypes of the Patent Rights
      in
      the Licensed Field, including any schematics, diagrams, designs and molds
      delivered to Zingo by Hybrid pursuant to Section 2.3, and Zingo, its Affiliates
      and Sublicensees may dispose of all previously made or partially made Licensed
      Product within a period of one hundred and twenty (120) days of the effective
      date of such termination provided that the sale of such Licensed Product by
      Zingo, its Sublicensees, or Affiliates shall be subject to the terms of this
      Agreement.

    6.6 Treatment
      of Sublicenses. Hybrid shall in good faith cooperate with Zingo to provide
      comfort to any Zingo sublicenses of the consequences of the termination of
      this
      Agreement. 

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    ARTICLE
      7.

    REPRESENTATIONS
      AND WARRANTY

    7.1 Representations
      and Warranties.

    (a) Hybrid
      represents and warrants:

    (1) that
      it
      is the sole owner of the Patent Rights and has the lawful right to grant this
      license;

    (2) that
      none
      of the Patent Rights are the subject of any pending interference, opposition,
      cancellation or other challenge or adversarial proceeding;

    (3) it
      has
      neither assigned nor granted any license or other rights to the Patent Rights
      and it is under no obligation to grant any such license or rights to any third
      party;

    (4) there
      are
      no outstanding liens, encumbrances, third party rights, agreements or
      understandings of any kind, either written, oral or implied, regarding the
      Patent Rights which are inconsistent or in conflict with any provision of this
      Agreement; and

    (5) the
      execution and delivery of this Agreement, and the performance by Hybrid of
      its
      obligations hereunder have been duly authorized by all necessary corporate
      or
      other action on the part of Hybrid, and no consents, waivers, or permissions
      that have not already been granted are required for such actions. 

    7.2 HYBRID
      HEREBY DISCLAIMS ANY IMPLIED WARRANTIES WITH RESPECT TO THE PATENT RIGHTS,
      INCLUDING WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY OR WARRANTY OF
      FITNESS FOR A PARTICULAR PURPOSE.

    

    ARTICLE
      8.

    MISCELLANEOUS
      PROVISIONS

    8.1 Correspondence.
      Any notice or payment required to be given to either party under this Agreement
      shall be deemed to have been properly given and effective: 

    (a) on
      the
      date of delivery if delivered in person, or

    (b) five
      (5)
      days after mailing if mailed by first-class or certified mail, postage paid,
      to
      the parties’ respective addresses set forth above, attention: President, or to
      such other address as is designated by written notice given to the other
      party.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    8.2 Assignability.
      Except as otherwise expressly provided under this Agreement, neither this
      Agreement nor any right or obligation hereunder may be assigned or otherwise
      transferred (whether voluntarily, by operation of law or otherwise) by either
      party, without the prior express written consent of the other party; provided,
      however, that either party may, without such consent, assign this Agreement
      and
      its rights and obligations hereunder in connection with the transfer or sale
      of
      all or substantially all of its business, whether through merger, reorganization
      or otherwise. In the event Hybrid determines to transfer any of the Patent
      Rights to any entity, Hybrid must notify such entity, and such entity must
      acknowledge, that the Patent Rights are subject to this Agreement.

    8.3 No
      Waiver. No waiver by either party of any breach or default of any covenant
      or
      agreement set forth in this Agreement shall be deemed a waiver as to any
      subsequent and/or similar breach or default.

    8.4 
      Separate
      Counsel for Zingo. Zingo Acknowledges and represents that it has been advised
      by
      its counsel as to this Agreement and has not been represented by Jackson &
Campbell, P.C.

    8.5 Failure
      to Perform. In the event of a failure of performance due under this Agreement
      and if it becomes necessary for either party to undertake legal action against
      the other on account thereof, then the prevailing party shall be entitled to
      reasonable attorney's fees in addition to costs and necessary
      disbursements.

    8.6 Governing
      Laws. THIS AGREEMENT SHALL BE INTERPRETED AND CONSTRUED IN ACCORDANCE WITH
      THE
      LAWS OF THE STATE OF NEVADA, without regard to the conflicts of laws principles
      thereof, but the scope and validity of any patent or patent application shall
      be
      governed by the applicable laws of the country of the patent or patent
      application. 

     

    8.7 Force
      Majeure. A party to this Agreement may be excused from any performance required
      herein if such performance is rendered impossible or unfeasible due to any
      catastrophe or other major event beyond its reasonable control, including,
      without limitation, war, riot, and insurrection; laws, proclamations, edicts,
      ordinances, or regulations; strikes, lockouts, or other serious labor disputes;
      and floods, fires, explosions, or other natural disasters. When such events
      have
      abated, the non-performing party's obligations herein shall resume.

    8.8 Headings.
      The headings of the several sections are inserted for convenience of reference
      only and are not intended to be a part of or to affect the meaning or
      interpretation of this Agreement.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    8.9 Entire
      Agreement. This Agreement embodies the entire understanding of the parties
      and
      supersedes all previous communications, representations or understandings,
      either oral or written, between the parties relating to the subject matter
      hereof.

    8.10 Amendments.
      No amendment or modification of this Agreement shall be valid or binding on
      the
      parties unless made in writing and signed on behalf of each party.

    8.11 Severability.
      In the event that any of the provisions contained in this Agreement is held
      to
      be invalid, illegal, or unenforceable in any respect, such invalidity,
      illegality or unenforceability shall not affect any other provisions of this
      Agreement, and this Agreement shall be construed as if the invalid, illegal,
      or
      unenforceable provisions had never been contained in it.

     

    

    IN
      WITNESS WHEREOF, both Hybrid and Zingo have executed this Agreement, in
      duplicate originals, by their respective and duly authorized officers on the
      day
      and year written.

    Zingo,
      Inc.:                                                             
Hybrid
      Technologies, Inc.

    /s/
      Mehboob Charania   
/s/
      Holly
      Roseberry

    By__________________________
        By___________________________

    (Signature)
        (Signature)

    Name:
      Mehboob
      Charania                                  
Name:
      Holly Roseberry

    Title:
      Secretary                                                      
Title:
      Chief Executive Officer

     

    EXHIBIT
      A

    List
      of
      Patents and Patent Applications

    

    22854-002-
      “Rechargeable Battery Cathode Material”- PTO assigned application # 60/947,168
      with a filing date of 06/29/2007- Inventor Sengupta, Surajit

     

    EXHIBIT
      B

    Equipment
      and Supplies to be Purchased from Hybrid Technologies, Inc.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

      

      
        	
                Date

              	
                Vendor

              	
                Amount

              	
                
                  PO
                    #

                

              	
                
                  Equipment
                    and Supplies

                

              
	 	
                 

              	
                 

              	 	 
	
                4/25/07

              	
                AHL
                  Machinery Corp

              	
                $21,750.00
                  

              	
                1159
                  

              	
                mixer,
                  temperature control system

              
	
                10/19/07

              	
                Alfa
                  Aesar

              	
                $2,505.00
                  

              	
                1186
                  

              	
                titanium,
                  polyvinyl alcohol

              
	 	 	
                $4,750

              	 	
                electric
                  hook up

              
	
                 

              	 	 	 	 
	
                Total

              	 	
                $29,005.00EXHIBIT
          10.13

        

        ROKWADER,
          INC.

        CODE
          OF BUSINESS CONDUCT AND ETHICS

         

        Rokwader,
          Inc. (the "Company") has adopted the following Code of Business Conduct
          and
          Ethics (this "Code") for directors and executive officers of the Company.
          This
          Code is intended to focus the Board and each director and executive officer
          on
          areas of ethical risk, provide guidance to directors and executive officer
          to
          help them recognize and deal with ethical issues, provide mechanisms to
          report
          unethical conduct, and help foster a culture of honesty and accountability.
          Each
          director and executive officer must comply with the letter and spirit of
          this
          Code.

         

        No
          code
          or policy can anticipate every situation that may arise. Accordingly, this
          Code
          is intended to serve as a source of guiding principles for directors and
          executive officers. Directors and executive officers are encouraged to
          bring
          questions about particular circumstances that may implicate one or more
          of the
          provisions of this Code to the attention of the Chairman of the Board,
          who may
          consult with inside or outside legal counsel as appropriate.

         

        1.
          MAINTAIN FIDUCIARY DUTIES

         

        Directors
          and executive officers must be loyal to the Company and must act at all
          times in
          the best interest of the Company and its shareholders and subordinate
          self-interest to the corporate and shareholder good. Directors and executive
          officers should never use their position to make a personal profit. Directors
          and executive officers must perform their duties in good faith, with sound
          business judgment and with the care of a prudent person.

         

        2.
          CONFLICT OF INTEREST.

         

        A
          "conflict of interest" occurs when the private interest of a director or
          executive officer interferes in any way, or appears to interfere, with
          the
          interests of the Company as a whole. Conflicts of interest also arise when
          a
          director or executive officer, or a member of his or her immediate family,
          receives improper personal benefits as a result of his or her position
          as a
          director or executive officer of the Company. Loans to, or guarantees of
          the
          obligations of, a director or executive officer, or a member of his or
          her
          family, are prohibited.

         

        Directors
          and executive officers must avoid conflicts of interest with the Company.
          Any
          situation that involves, or may reasonably be expected to involve, a conflict
          of
          interest with the Company must be disclosed immediately to the Chairman
          of the
          Board.

         

        The
          term
          "immediate family" in this Code is defined as to include a person's spouse,
          parents, children, siblings, mothers-in-law and fathers-in-law, sons and
          daughters-in-law, and anyone (other than employees of such person) who
          share
          such person's home.

         

        This
          Code
          does not attempt to describe all possible conflicts of interest which could
          develop. Some of the more common conflicts from which directors and executive
          offices must refrain, however, are set out below.

         

        o
          Relationship of Company with third-parties. Directors and executive officers
          may
          not engage in any conduct or activities that are inconsistent with the
          Company's
          best interests or that disrupt or impair the Company's relationship with
          any
          person or entity with which the Company has or proposes to enter into a
          business
          or contractual relationship.

         

        o
          Compensation from non-Company sources. Directors and executive officers
          may not
          accept compensation, in any form, for services performed for the Company
          from
          any source other than the Company.

         

        o
          Directors and executive officers and members of their families may not
          offer,
          give or receive gifts from persons or entities who deal with the Company
          in
          those cases where any such gift is being made in order to influence the
          actions
          of a director as member of the Board or the actions of an executive officer
          as
          an officer of the Company, or where acceptance of the gifts would create
          the
          appearance of a conflict of interest.

         

        3.
          CORPORATE OPPORTUNITIES.

         

        Directors
          and executive officers owe a duty to the Company to advance its legitimate
          interests when the opportunity to do so arises. Directors and executive
          officers
          are prohibited from: (a) taking for themselves personally opportunities
          that are
          discovered through the use of corporate property, information or the director's
          or executive officer's position; (b) using the Company's property, information,
          or position for personal gain; or (c) competing with the Company, directly
          or
          indirectly, for business opportunities, provided, however, if the Company's
          disinterested directors determine that the Company will not pursue an
          opportunity that relates to the Company's business, a director or executive
          officer may do so.

         

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        4.
          CONFIDENTIALITY.

         

        Directors
          and executive officers must maintain the confidentiality of information
          entrusted to them by the Company or its customers, and any other confidential
          information about the Company that comes to them, from whatever source,
          in their
          capacity as director or executive officer, except when disclosure is authorized
          or required by laws or regulations. Confidential information includes all
          non-public information that might be of use to competitors, or harmful
          to the
          Company or its customers, if disclosed.

         

        5.
          PROTECTION AND PROPER USE OF COMPANY ASSETS.

         

        Directors
          and executive officers must protect the Company's assets and ensure their
          efficient use. Theft, loss, misuse, carelessness and waste of assets have
          a
          direct impact on the Company's profitability. Directors and executive officers
          must not use Company time, employees, supplies, equipment, tools, buildings
          or
          other assets for personal benefit without prior authorization from the
          Chairman
          of the Board or as part of a compensation or expense reimbursement program
          available to all directors or executive officers.

         

        6.
          FAIR
          DEALING.

         

        Directors
          and executive officers shall deal fairly and oversee fair dealing by employees
          and officers with the Company's directors, officers, employees, customers,
          suppliers and competitors. None should take unfair advantage of anyone
          through
          manipulation, concealment, abuse of privileged information, misrepresentation
          of
          material facts or any other unfair dealing practices.

         

        7.
          COMPLIANCE WITH LAWS, RULES AND REGULATIONS.

         

        Directors
          and executive officers shall comply, and oversee compliance by employees,
          officers and other directors, with all laws, rules and regulations applicable
          to
          the Company, including federal securities laws.

         

        8.
          WAIVERS OF THE CODE OF BUSINESS CONDUCT AND ETHICS.

         

        Any
          waiver of this Code may be made only by the Board or a Board committee
          and must
          be promptly disclosed to the Company's shareholders.

         

        9.
          ENCOURAGING THE REPORTING OF ANY ILLEGAL OR UNETHICAL BEHAVIOR.

         

        Directors
          and executive officers should promote ethical behavior and take steps to
          ensure
          the Company (a) encourages employees to talk to supervisors, managers and
          other
          appropriate personnel when in doubt about the best course of action in
          a
          particular situation; (b) encourages employees to report violations of
          laws,
          rules or regulations to appropriate personnel; and (c) informs employees
          that
          the Company will not permit retaliation for reports made in good
          faith.

         

        10.
          FAILURE TO COMPLY; COMPLIANCE PROCEDURES.

         

        A
          failure
          by any director or executive officer to comply with the laws or regulations
          governing the Company's business, this Code or any other Company policy
          or
          requirement may result in disciplinary action, and, if warranted, legal
          proceedings.

         

        Directors
          and executive officers should communicate any suspected violations of this
          Code
          promptly to the Chairman of the Board. Violations will be investigated
          by the
          Board or by a person or persons designated by the Board and appropriate
          action
          will be taken in the event of any violations of this Code.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]